Patient-specific insulin-resistanceguided infusion improves glycemic control in cardiac surgery

Kirk A. Caddell, Christopher B. Komanapalli, Matthew Slater, Daniel Hagg, Frederick (Fred) Tibayan, Stephen Smith, Andrew Ahmann, Steven W. Guyton, Howard Song

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Maintenance of appropriate capillary blood glucose in cardiovascular surgery patients has been associated with improved outcomes, including lower mortality. Interpatient variability in insulin resistance can make management difficult, leading to unexpected episodes of hypoglycemia and hyperglycemia. To improve postoperative glucose control at our institution, a patient-specific insulin-resistanceguided (IRG) protocol was developed. Methods: Prospective data were gathered on 100 consecutive cardiovascular surgery patients managed with our standard insulin infusion protocol and 100 patients managed using the IRG protocol. Clinical characteristics and glycemic indices were analyzed for the two groups. Primary endpoints included (1) percentage of time spent in the target range, (2) number of hypoglycemic and hyperglycemic episodes, (3) time to achievement of target blood glucose, and (4) the total daily dose of insulin required. Results: The IRG protocol resulted in significant improvements, including increased percentage of time spent in the normoglycemic range (82.5% versus 65.8%, p <0.001), reduced rate of hypoglycemic episodes (0.12 versus 0.99, p <0.01), reduced rate of hyperglycemic episodes (capillary blood glucose >126 mg/dL: 4.8 versus 8.2, p <0.01), and a reduced time to the first measurement in the target range. Total daily dose of insulin was mildly increased, but failed to reach statistical significance (92.48 versus 82.64 units, p = 0.32). Conclusions: Use of the IRG protocol led to improved glycemic indices while reducing episodes of hypoglycemia in both diabetic and nondiabetic patients. The ability to adjust a patient's insulin dosing based upon factors related to their insulin resistance results in improved blood glucose control and safety in cardiovascular surgery patients.

Original languageEnglish (US)
Pages (from-to)1818-1823
Number of pages6
JournalAnnals of Thoracic Surgery
Volume90
Issue number6
DOIs
StatePublished - Dec 2010

Fingerprint

Thoracic Surgery
Insulin
Glycemic Index
Blood Glucose
Hypoglycemia
Insulin Resistance
Blood Safety
Aptitude
Hypoglycemic Agents
Hyperglycemia
Maintenance
Glucose
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Patient-specific insulin-resistanceguided infusion improves glycemic control in cardiac surgery. / Caddell, Kirk A.; Komanapalli, Christopher B.; Slater, Matthew; Hagg, Daniel; Tibayan, Frederick (Fred); Smith, Stephen; Ahmann, Andrew; Guyton, Steven W.; Song, Howard.

In: Annals of Thoracic Surgery, Vol. 90, No. 6, 12.2010, p. 1818-1823.

Research output: Contribution to journalArticle

Caddell, Kirk A. ; Komanapalli, Christopher B. ; Slater, Matthew ; Hagg, Daniel ; Tibayan, Frederick (Fred) ; Smith, Stephen ; Ahmann, Andrew ; Guyton, Steven W. ; Song, Howard. / Patient-specific insulin-resistanceguided infusion improves glycemic control in cardiac surgery. In: Annals of Thoracic Surgery. 2010 ; Vol. 90, No. 6. pp. 1818-1823.
@article{03c1f34fe67d442c8822625ac4cc05d6,
title = "Patient-specific insulin-resistanceguided infusion improves glycemic control in cardiac surgery",
abstract = "Background: Maintenance of appropriate capillary blood glucose in cardiovascular surgery patients has been associated with improved outcomes, including lower mortality. Interpatient variability in insulin resistance can make management difficult, leading to unexpected episodes of hypoglycemia and hyperglycemia. To improve postoperative glucose control at our institution, a patient-specific insulin-resistanceguided (IRG) protocol was developed. Methods: Prospective data were gathered on 100 consecutive cardiovascular surgery patients managed with our standard insulin infusion protocol and 100 patients managed using the IRG protocol. Clinical characteristics and glycemic indices were analyzed for the two groups. Primary endpoints included (1) percentage of time spent in the target range, (2) number of hypoglycemic and hyperglycemic episodes, (3) time to achievement of target blood glucose, and (4) the total daily dose of insulin required. Results: The IRG protocol resulted in significant improvements, including increased percentage of time spent in the normoglycemic range (82.5{\%} versus 65.8{\%}, p <0.001), reduced rate of hypoglycemic episodes (0.12 versus 0.99, p <0.01), reduced rate of hyperglycemic episodes (capillary blood glucose >126 mg/dL: 4.8 versus 8.2, p <0.01), and a reduced time to the first measurement in the target range. Total daily dose of insulin was mildly increased, but failed to reach statistical significance (92.48 versus 82.64 units, p = 0.32). Conclusions: Use of the IRG protocol led to improved glycemic indices while reducing episodes of hypoglycemia in both diabetic and nondiabetic patients. The ability to adjust a patient's insulin dosing based upon factors related to their insulin resistance results in improved blood glucose control and safety in cardiovascular surgery patients.",
author = "Caddell, {Kirk A.} and Komanapalli, {Christopher B.} and Matthew Slater and Daniel Hagg and Tibayan, {Frederick (Fred)} and Stephen Smith and Andrew Ahmann and Guyton, {Steven W.} and Howard Song",
year = "2010",
month = "12",
doi = "10.1016/j.athoracsur.2010.05.054",
language = "English (US)",
volume = "90",
pages = "1818--1823",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Patient-specific insulin-resistanceguided infusion improves glycemic control in cardiac surgery

AU - Caddell, Kirk A.

AU - Komanapalli, Christopher B.

AU - Slater, Matthew

AU - Hagg, Daniel

AU - Tibayan, Frederick (Fred)

AU - Smith, Stephen

AU - Ahmann, Andrew

AU - Guyton, Steven W.

AU - Song, Howard

PY - 2010/12

Y1 - 2010/12

N2 - Background: Maintenance of appropriate capillary blood glucose in cardiovascular surgery patients has been associated with improved outcomes, including lower mortality. Interpatient variability in insulin resistance can make management difficult, leading to unexpected episodes of hypoglycemia and hyperglycemia. To improve postoperative glucose control at our institution, a patient-specific insulin-resistanceguided (IRG) protocol was developed. Methods: Prospective data were gathered on 100 consecutive cardiovascular surgery patients managed with our standard insulin infusion protocol and 100 patients managed using the IRG protocol. Clinical characteristics and glycemic indices were analyzed for the two groups. Primary endpoints included (1) percentage of time spent in the target range, (2) number of hypoglycemic and hyperglycemic episodes, (3) time to achievement of target blood glucose, and (4) the total daily dose of insulin required. Results: The IRG protocol resulted in significant improvements, including increased percentage of time spent in the normoglycemic range (82.5% versus 65.8%, p <0.001), reduced rate of hypoglycemic episodes (0.12 versus 0.99, p <0.01), reduced rate of hyperglycemic episodes (capillary blood glucose >126 mg/dL: 4.8 versus 8.2, p <0.01), and a reduced time to the first measurement in the target range. Total daily dose of insulin was mildly increased, but failed to reach statistical significance (92.48 versus 82.64 units, p = 0.32). Conclusions: Use of the IRG protocol led to improved glycemic indices while reducing episodes of hypoglycemia in both diabetic and nondiabetic patients. The ability to adjust a patient's insulin dosing based upon factors related to their insulin resistance results in improved blood glucose control and safety in cardiovascular surgery patients.

AB - Background: Maintenance of appropriate capillary blood glucose in cardiovascular surgery patients has been associated with improved outcomes, including lower mortality. Interpatient variability in insulin resistance can make management difficult, leading to unexpected episodes of hypoglycemia and hyperglycemia. To improve postoperative glucose control at our institution, a patient-specific insulin-resistanceguided (IRG) protocol was developed. Methods: Prospective data were gathered on 100 consecutive cardiovascular surgery patients managed with our standard insulin infusion protocol and 100 patients managed using the IRG protocol. Clinical characteristics and glycemic indices were analyzed for the two groups. Primary endpoints included (1) percentage of time spent in the target range, (2) number of hypoglycemic and hyperglycemic episodes, (3) time to achievement of target blood glucose, and (4) the total daily dose of insulin required. Results: The IRG protocol resulted in significant improvements, including increased percentage of time spent in the normoglycemic range (82.5% versus 65.8%, p <0.001), reduced rate of hypoglycemic episodes (0.12 versus 0.99, p <0.01), reduced rate of hyperglycemic episodes (capillary blood glucose >126 mg/dL: 4.8 versus 8.2, p <0.01), and a reduced time to the first measurement in the target range. Total daily dose of insulin was mildly increased, but failed to reach statistical significance (92.48 versus 82.64 units, p = 0.32). Conclusions: Use of the IRG protocol led to improved glycemic indices while reducing episodes of hypoglycemia in both diabetic and nondiabetic patients. The ability to adjust a patient's insulin dosing based upon factors related to their insulin resistance results in improved blood glucose control and safety in cardiovascular surgery patients.

UR - http://www.scopus.com/inward/record.url?scp=78649424007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649424007&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2010.05.054

DO - 10.1016/j.athoracsur.2010.05.054

M3 - Article

C2 - 21095317

AN - SCOPUS:78649424007

VL - 90

SP - 1818

EP - 1823

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 6

ER -